Condition: Advanced Solid Tumor · Metastatic Solid Tumor · Gastric Adenocarcinoma · Sponsor: Kyowa Kirin Co., Ltd.
This is a first-in-human study of KK2269. Part 1 and Part 2 will be conducted as a multicenter, open-label, non-randomized, dose-escalation study. Participants with advanced or metastatic solid tumors for which no standard therapy is available will be enrolled in Part 1. In Part 1, the primary objective is to assess the safety and tolerability of KK2269. In Part 2, only participants with gastric adenocarcinoma, GEJ adenocarcinoma, esophageal adenocarcinoma, or NSCLC who have experienced at least one systemic therapy will be enrolled. In Part 2, the primary objective is to assess the safety and tolerability of KK2269 in combination with docetaxel and to determine the recommended dose(s) and dose interval(s) of KK2269 in combination with docetaxel for subsequent studies. In both Part 1 and Part 2, participants who refuse to undergo standard therapy are also eligible.
This description comes directly from the study's public registry record.
Kyowa Kirin Co., Ltd. · +81-3-5205-7200 · clinical.info.jp@kyowakirin.com
Kyowa Kirin, Inc. · 609-919-1100 · kkd.clintrial.82@kyowakirin.com
Always discuss trial participation with your own doctor first.
| Mayo Clinic Arizona | Scottsdale, Arizona, United States | Recruiting |
| City Of Hope National Medical Center | Duarte, California, United States | Recruiting |
| Hoag Memorial Hospital Presbyterian | Newport Beach, California, United States | Recruiting |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | Recruiting |
| Washington University | St Louis, Missouri, United States | Recruiting |
| The University of Texas Southwestern Medical Center | Dallas, Texas, United States | Recruiting |
| University of Washington | Seattle, Washington, United States | Recruiting |
| Aichi Cancer Center | Nagoya, Aichi-ken, Japan | Recruiting |
| National Cancer Center Hospital East | Kashiwa, Chiba, Japan | Recruiting |
| National Cancer Center Hospital | Chuo-ku, Tokyo, Japan | Recruiting |
| Cancer Institute Hospital of JFCR | Koto-Ku, Tokyo, Japan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06266299